Editorial
Copyright ©The Author(s) 2024.
World J Gastrointest Pharmacol Ther. May 5, 2024; 15(2): 91591
Published online May 5, 2024. doi: 10.4292/wjgpt.v15.i2.91591
Table 1 Mean times (in weeks) for various induction therapies to reach a particular endpoint in ulcerative colitis
TherapyTreatment endpoints
Clinical response
Clinical remission
Normalisation CRP/ESR
Decrease of faecal calprotectin
Mucosal healing
Oral 5-aminosalicylates4881013
Oral steroids225811
Locally acting steroids388913
Thiopurines1115151520
Adalimumab611101214
Infliximab51091113
Vedolizumab914141518
Tofacitinib61191114
Table 2 Suggested table for documentation of treatment endpoints in ulcerative colitis
Time frame
Short term
Medium term
Long term
Proposed duration6-8 wk12-16 wk26-52 wk
Endpoint typeMinimum endpointsIdeal endpointsMinimum endpointsIdeal endpointsMinimum endpointsIdeal endpoints
EndpointsClinical response; Biochemical response; IUS responseClinical remission; Biochemical remission; IUS remissionClinical remission; IUS response; Endoscopic response IUS remission; Endoscopic remission Endoscopic remission; Histologic responseEndoscopic healing; Histologic healing; Gut barrier function restoration